Abstract
The effect of rifampicin pre-treatment (600 mg daily for 6 days) on theophylline disposition at steady state was investigated in six healthy males. Following rifampicin treatment total plasma clearance of theophylline increased by 82%. Theophylline clearance through each metabolic pathway was increased, 1-demethylation by (116 +/- 34%) (mean +/- s.e. mean), 3-demethylation by (91 +/- 16%) and 8-oxidation by (81 +/- 17%). Renal clearance of unchanged drug was not altered. Previous studies have suggested that two forms of cytochrome P-450 are involved in theophylline metabolism, one mediating the N-demethylations and the other 8-oxidation. Thus, unlike the selective inductive effect of rifampicin on antipyrine metabolic pathways, rifampicin does not differentially affect those forms of cytochrome P-450 involved in theophylline metabolism. The extent to which theophylline metabolism is induced by rifampicin is likely to have important clinical consequences.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Birkett D. J., Miners J. O., Attwood J. Evidence for a dual action of sulphinpyrazone on drug metabolism in man: theophylline-sulphinpyrazone interaction. Br J Clin Pharmacol. 1983 May;15(5):567–569. doi: 10.1111/j.1365-2125.1983.tb02093.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Birkett D. J., Miners J. O., Attwood J. Secondary metabolism of theophylline biotransformation products in man--route of formation of 1-methyluric acid. Br J Clin Pharmacol. 1983 Jan;15(1):117–119. doi: 10.1111/j.1365-2125.1983.tb01475.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Grygiel J. J., Birkett D. J. Cigarette smoking and theophylline clearance and metabolism. Clin Pharmacol Ther. 1981 Oct;30(4):491–496. doi: 10.1038/clpt.1981.193. [DOI] [PubMed] [Google Scholar]
- Grygiel J. J., Wing L. M., Farkas J., Birkett D. J. Effects of allopurinol on theophylline metabolism and clearance. Clin Pharmacol Ther. 1979 Nov;26(5):660–667. doi: 10.1002/cpt1979265660. [DOI] [PubMed] [Google Scholar]
- O'Reilly R. A. Interaction of sodium warfarin and rifampin. Studies in man. Ann Intern Med. 1974 Sep;81(3):337–340. doi: 10.7326/0003-4819-81-3-337. [DOI] [PubMed] [Google Scholar]
- Piafsky K. M., Sitar D. S., Ogilvie R. I. Effect of phenobarbital on the disposition of intravenous theophylline. Clin Pharmacol Ther. 1977 Sep;22(3):336–339. doi: 10.1002/cpt1977223336. [DOI] [PubMed] [Google Scholar]
- Self T. H., Self M. M., Worden J. P., Jr, Taylor W. S., Straughn A. B. Noneffect of rifampin on theophylline disposition in rabbits. Res Commun Chem Pathol Pharmacol. 1982 Dec;38(3):505–508. [PubMed] [Google Scholar]
- Toverud E. L., Boobis A. R., Brodie M. J., Murray S., Bennett P. N., Whitmarsh V., Davies D. S. Differential induction of antipyrine metabolism by rifampicin. Eur J Clin Pharmacol. 1981;21(2):155–160. doi: 10.1007/BF00637517. [DOI] [PubMed] [Google Scholar]
- Zilly W., Breimer D. D., Richter E. Induction of drug metabolism in man after rifampicin treatment measured by increased hexobarbital and tolbutamide clearance. Eur J Clin Pharmacol. 1975 Dec 19;9(2-3):219–227. doi: 10.1007/BF00614021. [DOI] [PubMed] [Google Scholar]